← Back to front page
United States · Wires & real time · PR Newswire

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Published by PR Newswire · United States 1 h ago

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery, development…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

What to consider if a company that made AI-related job cuts wants you back

 Business Wire

Roblox Reports Third Quarter 2026 Financial Results

 Dow Jones Newswires

Takeaways from the Inaugural Dow Jones Energy Forum

 MT Newswires

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows